Nakagawa Makoto 中川亮

Researcher Number	20808878
Other IDs
Affiliation (based on the past Project Information) *help	2020: 九州大学, 大学病院, 学術研究員 2019: 国立研究開発法人国立がん研究センター, 中央病院, 医員 2018: 国立研究開発法人国立がん研究センター, 研究所, 特任研究員
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator ヒストンメチル化酵素 / 癌幹細胞 / 多発性骨髄腫 / WNT/β-cateninシグナル / PRC2 / WNT/β-catenin / Side population / 骨髄腫幹細胞 / EZH1/2

Development of novel stem cell-targeted therapy for multiple myeloma based on dual inhibition of EZH1/2Principal Investigator
- Principal Investigator
  
  Nakagawa Makoto
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kyushu University
  National Cancer Center Japan

All 2021 2019 2018

All Journal Article Presentation

[Journal Article] CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib2021
- Author(s)
  Kagiyama Yuki、Fujita Shuhei、Shima Yutaka、Yamagata Kazutsune、Katsumoto Takuo、Nakagawa Makoto、Honma Daisuke、Adachi Nobuaki、Araki Kazushi、Kato Ayako、Inaki Koichiro、Ono Yoshimasa、Fukuhara Suguru、Kobayashi Yukio、Tobinai Kensei、Kitabayashi Issay
- Journal Title
  
  Cancer Science
  
  Volume: 印刷中 Issue: 6 Pages: 2314-2324
- DOI
  10.1111/cas.14905
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K16101
[Journal Article] 造血器腫瘍におけるEZH1/2を標的とした新規治療2019
- Author(s)
  中川亮, 北林一生
- Journal Title
  
  腫瘍内科
  
  Volume: 24 Pages: 704-710
- NAID
  40022108694
- Data Source
  KAKENHI-PROJECT-18K16101
[Journal Article] Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies2018
- Author(s)
  Nakagawa Makoto、Kitabayashi Issay
- Journal Title
  
  Cancer Science
  
  Volume: 109 Issue: 8 Pages: 2342-2348
- DOI
  10.1111/cas.13655
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K16101
[Journal Article] Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma2018
- Author(s)
  Nakagawa Makoto、Fujita Shuhei、Katsumoto Takuo、Yamagata Kazutsune、Ogawara Yoko、Hattori Ayuna、Kagiyama Yuki、Honma Daisuke、Araki Kazushi、Inoue Tatsuya、Kato Ayako、Inaki Koichiro、Wada Chisa、Ono Yoshimasa、Yamamoto Masahide、Miura Osamu、Nakashima Yasuharu、Kitabayashi Issay
- Journal Title
  
  Cancer Science
  
  Volume: 110 Issue: 1 Pages: 194-208
- DOI
  10.1111/cas.13840
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07188, KAKENHI-PROJECT-18K16101
[Presentation] Dual inhibition of EZH1/2 depletes stem cells and over-activates WNT signaling in multiple myeloma2018
- Author(s)
  Makoto Nakagawa, Takuo Katsumoto, Kazutsune Yamagata, Yoko Ogawara, Ayuna Hattori, Yukiko Aikawa, Daisuke Honma, Kazushi Araki, Tatsuya Inoue, Ayako Kato, Koichiro Inaki, Chisa Wada, Yoshimasa Ono, Yasuharu Nakashima, Issay Kitabayashi
- Organizer
  第16回幹細胞シンポジウム
- Data Source
  KAKENHI-PROJECT-18K16101

1. 小川原陽子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Nakagawa Makoto 中川亮

Research Projects

Research Products

Co-Researchers

Development of novel stem cell-targeted therapy for multiple myeloma based on dual inhibition of EZH1/2Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 造血器腫瘍におけるEZH1/2を標的とした新規治療2019

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] Dual inhibition of EZH1/2 depletes stem cells and over-activates WNT signaling in multiple myeloma2018

Author(s)

Organizer

Data Source

Nakagawa Makoto 中川 亮

Research Projects

Research Products

Co-Researchers

Development of novel stem cell-targeted therapy for multiple myeloma based on dual inhibition of EZH1/2Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 造血器腫瘍におけるEZH1/2を標的とした新規治療2019

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] Dual inhibition of EZH1/2 depletes stem cells and over-activates WNT signaling in multiple myeloma2018

Author(s)

Organizer

Data Source

Nakagawa Makoto 中川亮